BOCH
Blue Owl Capital Holdings Portfolio holdings
AUM
$322M
1-Year Est. Return
19.98%
1 Year Est. Return
+19.98%
AUM
$322M
AUM Growth
+$12.3M
(+4%)
Holding
80
Top Buys
| 1 | +$15M | |
| 2 | +$5.03M | |
| 3 | +$4.46M | |
| 4 |
Immuneering
IMRX
|
+$3.85M |
| 5 |
Larimar Therapeutics
LRMR
|
+$2.99M |
Top Sells
| 1 | +$15.9M | |
| 2 | +$13.1M | |
| 3 | +$8.91M | |
| 4 |
Tango Therapeutics
TNGX
|
+$5.84M |
| 5 |
TEM
Tempus AI
TEM
|
+$5.09M |
Sector Composition
| 1 | Healthcare | 56.77% |
| 2 | Financials | 22.9% |
| 3 | Technology | 12.32% |
| 4 | Consumer Discretionary | 7.01% |
| 5 | Energy | 0.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Nuveen Churchill Direct Lending
NCDL
$728M
| $42.7M | 13.24% |
3,091,553
-948,000
|
|
||
2
Blue Owl Capital
OBDC
$6.84B
| $26.1M | 8.11% |
2,045,070
|
|
||
3
enGene Holdings
ENGN
$543M
| $22.4M | 6.95% |
3,278,106
-450,000
|
|
||
|
4
Larimar Therapeutics
LRMR
$339M
| $18.9M | 5.87% |
5,853,040
+925,000
|
|
||
5
EverCommerce
EVCM
$1.79B
| $18.3M | 5.67% |
1,641,929
|
|
||
6
Holley
HLLY
$496M
| $15.3M | 4.74% |
4,862,361
+750,000
|
|
||
7
Roivant Sciences
ROIV
$14.1B
| $15M | 4.64% |
+988,249
|
|
||
8
Cullinan Oncology
CGEM
$740M
| $14.9M | 4.62% |
2,510,972
+125,000
|
|
||
9
Ultragenyx Pharmaceutical
RARE
$3.48B
| $12.7M | 3.94% |
422,438
+167,200
|
|
||
10
Conduent
CNDT
$315M
| $12.5M | 3.87% |
4,456,848
|
|
||
11
Sagimet Biosciences
SGMT
$206M
| $9.11M | 2.83% |
1,328,351
|
|
||
12
Compass Therapeutics
CMPX
$928M
| $9.07M | 2.82% |
2,591,525
|
|
||
13
Dell
DELL
$92.1B
| $7.42M | 2.3% |
52,334
+31,486
|
|
||
14
Civeo
CVEO
$256M
| $7.3M | 2.27% |
317,411
|
|
||
15
Context Therapeutics
CNTX
$91.9M
| $7.18M | 2.23% |
7,407,906
|
|
||
16
Aquestive Therapeutics
AQST
$737M
| $6.99M | 2.17% |
1,250,000
+330,000
|
|
||
17
Disc Medicine
IRON
$3.46B
| $6.76M | 2.1% |
102,260
-20,000
|
|
||
18
Repare Therapeutics
RPTX
$92.8M
| $6.06M | 1.88% |
3,443,659
|
|
||
|
PVLA
19
Palvella Therapeutics
PVLA
$1.15B
| $5.97M | 1.85% |
95,259
-30,000
|
|
||
20
EyePoint, Inc. Common Stock
EYPT
$1.4B
| $5.23M | 1.62% |
367,594
-195,000
|
|
||
21
Korro Bio
KRRO
$69.8M
| $5.03M | 1.56% |
105,000
-20,000
|
|
||
|
IMA
22
ImageneBio Inc
IMA
$72.2M
| $4.41M | 1.37% |
540,924
+199,997
|
|
||
23
Pliant Therapeutics
PLRX
$78M
| $4.39M | 1.36% |
2,969,199
|
|
||
|
CNTA
24
Centessa Pharmaceuticals
CNTA
$4.34B
| $4.11M | 1.28% |
169,450
-161,150
|
|
||
|
25
Immuneering
IMRX
$389M
| $3.85M | 1.2% |
+550,000
|
|